State to negotiate medicine pricing agreement with pharma firms
Discussions with the industry body IPHA are already underway, with formal negotiations expected to kick off next month.
The Department of Public Expenditure and Reform (DPER) will be centrally involved in the negotiation of a new medicine pricing agreement with the Irish Pharmaceutical Healthcare Association (IPHA).
Discussions with the industry body are already underway, with formal negotiations expected to kick off next month.
A spokesman for health minister Leo Varadkar said that the state was using a “coordinated approach” involving the Department of Health, the HSE, the Department of Public Expenditure and Reform,...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month, €19.99 Monthly thereafter
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Susan O’Keeffe: The state is still failing mother and baby homes victims
Instead of doubling its efforts to make up for past sins, the state is doubling down to avoid the practical consequences of those acts of cruelty and degradation against thousands of babies
Comment: Taking data as certain can lead to dangerous decisions
As economists and policymakers increasingly rely on data-based machine-learning and AI systems, we must be clear about its limitations
James O’Connor: Ireland could turn a higher rate of corporate tax into a win-win
The global tax regime is changing and we face losing out significantly if we do not consider a new approach to our competitiveness
Michael Brennan: Acid test of Greens’ peace deal will be what happens in Dublin Bay South
Hazel Chu insists there is ‘no squabble’ with Eamon Ryan, the Green Party leader, but time and the next general election will tell
